Apollo Hospitals Share Price

    NSE
    7352
    +132.00 (1.81%)
    APOLLOHOSP • 15 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    14.05%

    3Y Annualised Return

    23.13%

    5Y Annualised Return

    37.49%

    The current prices are delayed, login or Open Demat Account for live prices.

    Apollo Hospitals Stock Performance

    1W Return-2.70
    1Y Return14.34
    Today's Low7227.5
    Prev. Close7,220.00
    Mkt Cap (Cr.)1,05,832.70
    1M Return5.23
    3Y Return87.21
    52-Week High7635
    Open7,260.50
    PE Ratio81.69
    6M Return9.99
    Today's High7374
    52-Week Low6001
    Face Value5

    Apollo Hospitals Company background

    Founded in: 1979
    Managing director: Suneeta Reddy

    Founded in: 1979 Managing director: Suneeta Reddy

    Apollo Hospitals Enterprise Limited (AHEL) is a very well-known name in private healthcare in Asia. They're renowned for setting high standards in healthcare. But hospitals are not all they do. Apollo also has their hands in pharmacies, primary care clinics, and diagnostic services.

    Apollo's adventure started on December 5, 1979. That’s when they opened their very first 250-bed hospital in Chennai, India. The goal? To provide specialty and super-specialty medical services like Indians had never seen before. 1985, and they were already expanding with 46 more beds, actually establishing themselves as a major player in the healthcare game.

    Through the years, Apollo Hospitals has been sort of a pioneer in transforming the Indian healthcare scene. One of their big moves was introducing corporate healthcare delivery. Now why’s that important? It helped make high-quality healthcare more accessible and affordable for a lot more folks.

    Expanding Facilities and Innovations in Healthcare

    Back in 1986, Apollo Hospitals launched the Apollo Health Association (AHA) to introduce some fresh health insurance options. Do note that this was actually a game-changer—it gave people access to world-class healthcare across 76 top hospitals in select cities, making high-quality medical care more affordable.

    In the late 80s, and Apollo was leading the charge in healthcare tech. In 1989, they were the first to bring Magnetic Resonance Imaging (MRI) to India, revolutionizing medical diagnostics. They didn’t stop there; they also rolled out some cutting-edge tech like the SOMATOMCR CT scanner, breast-scanning tools, and video endoscopy, which helped catch serious conditions like carcinoma early.

    Same year Apollo teamed up with the USSR's I.R.T.C. of Eye Microsurgery to open the Apollo Fyodorov Eye Research Institute. They dived into advanced research and treatments in eye care. But, there's more! In 1991, they launched the Apollo School of Nursing to offer nurses top-tier training and set them up for successful careers.

    Expansion and Internationalization

    Apollo Hospitals didn't just grow quietly; they kept adding new departments focusing on specialized health services. Back in 1993, they opened a cancer hospital with 150 beds, putting a big emphasis on cutting-edge care and research. It was a big step forward for them.

    Then, in 1995, and they opened another cancer hospital, this time in Hyderabad. That was a really big deal for them and a key moment in their growth story.

    By the time 1998 rolled around, Apollo Hospitals decided to take a bold step onto the international stage. They teamed up with the Sri Lankan government and opened a super-specialty hospital in Colombo. Do note that this move marked the beginning of Apollo’s adventure into the world market.

    Strategic Partnerships

    Teaming up with others has been key to Apollo's success. 1997 they joined forces with Jardine, a company from the UK, to bring Health Maintenance Organizations (HMOs) to India. This move was all about matching up with international healthcare standards.

    Then, in 2001, Apollo struck another important partnership, this time with the government of Mauritius. This collaboration helped them become a top healthcare provider for the people there. Through these partnerships, Apollo Hospitals have been able to keep up with the latest in healthcare innovations and spread their wings globally.

    Technology Integration and Innovations

    In 2004, Apollo Hospitals took a big step by teaming up with the Defence Research and Development Organisation (DRDO). They combined their strengths to boost the hospital’s technology. This partnership brought about some cutting-edge medical services, like the Apollo National Heart Plan, which is a full health program that focuses on everything from prevention to disease management and treatment.

    By 2005, Apollo had significantly upgraded its technological setup. Did you know that their hospital in Delhi earned the prestigious Joint Commission International (JCI) certification? Note that it is a big deal because it recognizes excellence in quality care and safety.

    Diversification into Health Insurance and New Ventures

    As part of upping its game, Apollo Hospitals jumped into the health insurance market. In 2006, they joined forces with Deutsche Krankenversicherung AG (DKV) so as to form a joint venture focused on health insurance. Do note that this move was all about boosting their healthcare services and offering a more complete package for patient care.

    Then Apollo went big on research too. In 2009, they opened a clinical trial facility in Hyderabad, joining hands with Quintiles Mauritius Holdings Inc. so as to conduct Phase I clinical trials. This was a major step forward in showing their dedication to medical research and innovation.

    Plus, they poured resources into new facilities like the Apollo Health City in Hyderabad. This enormous 33-acre site offers all sorts of integrated healthcare services, from prevention and management to wellness and research.

    Growth in the Retail Pharmacy Sector

    Apollo Hospitals Enterprise has made great progress in the retail pharmacy industry. In 2014, they expanded their market presence by acquiring 320 pharmacy stores from Hetero Med Solutions Limited. This expansion was a big step, increasing their reach in regions like Telangana, Andhra Pradesh, and Tamil Nadu. This strategic move allowed Apollo to improve their operational efficiency and achieve economies of scale, leading to increased profitability and a wider market reach.

    2022, and Apollo made another smart move by transferring its pharmacy distribution and the Apollo 24/7 digital healthcare platform to Apollo HealthCo Limited, a wholly-owned subsidiary. This transaction, worth Rs 12,100 million, aligns with Apollo's strategy to concentrate on core healthcare services while giving them a strong foothold in the booming digital healthcare market.

    International Expansion and Global Partnerships

    Apollo Hospitals Enterprise has been making big moves to go global. One of their standout projects was joining forces with the Hainan Ecological Smart City Group (HESCG) in China so as to set up a cutting-edge hospital in Hainan Province. This partnership is all about bringing Apollo’s expertise in hospital management and medical services to China's booming healthcare scene.

    Apollo is keen to connect with international financial bodies and healthcare partners. For example, in December 2016, they landed a huge equity investment of Rs 450 crore from the International Finance Corporation (IFC). This deal gave IFC a 29.03% stake in Apollo Health and Lifestyle Limited (AHLL), a company fully owned by Apollo. This investment was a game-changer, helping AHLL spread its wings and grow its retail healthcare services, which include primary health clinics, day surgery centers, and birthing centers.

    Financial Performance and Strategic Investments

    Apollo Hospitals has been doing well financially over the years, thanks to its expanding network of hospitals, retail pharmacies, and healthcare services. The Apollo Hospitals Enterprise share price has mirrored this success. In a notable financial move in 2021, Apollo Hospitals raised a significant amount of money through a Qualified Institutional Placement (QIP). By issuing 4.66 million shares at Rs 2511 each, they pulled in about Rs 1,170 crore.

    In addition to raising capital, Apollo has fine-tuned its finances by selling off non-core assets. Back in 2016, for instance, they sold their 23.3% stake in Apollo Munich Health Insurance to Munich Re for Rs 163.5 crore. By shedding these non-central assets, Apollo has been able to concentrate more on their primary healthcare services while extracting value from peripheral parts of the business. Their strategy of focusing on core healthcare operations while smartly managing acquisitions, expansions, and divestments keeps them poised for long-term success.

    As of 15 Jul, 2025, Apollo Hospitals share price is ₹7360.5. The stock opened at ₹7260.5 and had closed at ₹7220 the previous day. During today’s trading session, Apollo Hospitals share price moved between ₹7,227.50 and ₹7,374.00, with an average price for the day of ₹7300.75. Over the last 52 weeks, the stock has recorded a low of ₹6,001.00 and a high of ₹7,635.00. In terms of performance, Apollo Hospitals share price has increased by 9.8% over the past six months and has increased by 14.05% over the last year.

    Read More
    Apollo Hospitals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹69,80,532 (+7.39%)
    Daily SIP of 25,000 would have become 69,80,532 in 1 year with a gain of 4,80,532 (+7.39%)
    View details of Market Depth

    Apollo Hospitals Fundamental

    Market Cap (in crs)

    1,05,832.70

    Face Value

    5

    Turnover (in lacs)

    38,125.77

    Key Metrics

    Qtr Change %
    New 52W High in past week
    8.6
    Dividend yield 1yr %
    Below industry Median
    0.3

    Apollo Hospitals Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Apollo Hospitals Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    5592.2 Cr
    5526.9 Cr
    5589.3 Cr
    5085.6 Cr
    4943.9 Cr
    Apollo Hospitals Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    21994.3 Cr
    19165.5 Cr
    16702.8 Cr
    14740.8 Cr
    10605 Cr
    11273.7 Cr
    Apollo Hospitals Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    404 Cr
    374.1 Cr
    390 Cr
    304 Cr
    249.8 Cr
    Apollo Hospitals Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    1472.1 Cr
    917 Cr
    887.5 Cr
    1101.1 Cr
    136 Cr
    434.8 Cr

    Apollo Hospitals Result Highlights

    • Apollo Hospitals Enterprise Ltd reported a 11.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 15.1%.

    • Its expenses for the quarter were down by 8.8% QoQ and up 13.4% YoY.

    • The net profit decreased 31.9% QoQ and increased 77.4% YoY.

    • The earnings per share (EPS) of Apollo Hospitals Enterprise Ltd stood at 17.6 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Apollo Hospitals

    Promoter
    29.3%
    Foreign Institutions
    43.5%
    Mutual Funds
    15.9%
    Domestic Institutions
    21.6%
    Public
    5.6%
    Promoter
    29.3%
    Foreign Institutions
    42.7%
    Mutual Funds
    15.4%
    Domestic Institutions
    22.6%
    Public
    5.4%
    Promoter
    29.3%
    Foreign Institutions
    45.3%
    Mutual Funds
    12.8%
    Domestic Institutions
    20.2%
    Public
    5.2%
    Promoter
    29.3%
    Foreign Institutions
    45.4%
    Mutual Funds
    12.8%
    Domestic Institutions
    20.1%
    Public
    5.1%
    Promoter
    29.3%
    Foreign Institutions
    43.9%
    Mutual Funds
    14.7%
    Domestic Institutions
    21.4%
    Public
    5.4%
    Promoter
    29.3%
    Foreign Institutions
    45.6%
    Mutual Funds
    14.3%
    Domestic Institutions
    19.8%
    Public
    5.3%

    Apollo Hospitals Technical Analysis

    Moving Averages Analysis
    7352
    Current Price
    Bullish Moving Averages
    15
    Bearish Moving Averages
    1
    5Day EMA
    7,333.10
    10Day EMA
    7,348.80
    12Day EMA
    7,340.90
    20Day EMA
    7,288.40
    26Day EMA
    7,248.40
    50Day EMA
    7,124.40
    100Day EMA
    6,991.00
    200Day EMA
    6,840.80
    5Day SMA
    7,319.60
    10Day SMA
    7,433.80
    20Day SMA
    7,277.40
    30Day SMA
    7,170.40
    50Day SMA
    7,081.30
    100Day SMA
    6,832.40
    150Day SMA
    6,884.70
    200Day SMA
    6,916.60
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    360216 Rs
    522301 Rs
    Week Rs
    349625 Rs
    494336 Rs
    Month Rs
    338355 Rs
    538868 Rs
    7,320.67
    Pivot
    Resistance
    First Resistance
    7,413.83
    Second Resistance
    7,467.17
    Third Resistance
    7,560.33
    Support
    First Support
    7,267.33
    Second support
    7,174.17
    Third Support
    7,120.83
    Relative Strength Index
    55.41
    Money Flow Index
    62.19
    MACD
    92.48
    MACD Signal
    114.51
    Average True Range
    130.32
    Average Directional Index
    28.59
    Rate of Change (21)
    3.46
    Rate of Change (125)
    7.62
    Name
    Holding Percent
    MIRAE ASSET MIDCAP FUND
    2.21
    HDFC TRUSTEE COMPANY LIMITED
    1.62
    SBI NIFTY 50 ETF
    1.45
    AXIS MUTUAL FUND TRUSTEE LIMITED
    1.27
    INVESCO INDIA CONTRA FUND
    1.23
    NIPPON LIFE INDIA TRUSTEE LTD
    1.2
    ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED
    1.14
    FRANKLIN INDIA FLEXI CAP FUND
    1.12
    GOVERNMENT OF SINGAPORE
    1.49
    GOVERNMENT PENSION FUND GLOBAL
    1.14
    SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES
    1.03
    KOTAK FUNDS - INDIA MIDCAP FUND
    1.02
    LIFE INSURANCE CORPORATION OF INDIA
    2.17

    Apollo Hospitals Latest News

    08 JUL 2025 | Tuesday

    Apollo Hospitals Enterprise Ltd - 508869 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    08 JUL 2025 | Tuesday

    Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    03 JUL 2025 | Thursday

    'Buy' Apollo Hospitals Maintains HDFC Securities, Hikes Target Price Here's Why

    View More

    Apollo Hospitals Share Price FAQs

    Apollo Hospitals share price is ₹7352 in NSE and ₹7361.5 in BSE as on 15/7/2025.

    Apollo Hospitals share price in the past 1-year return was 14.34. The Apollo Hospitals share hit a 1-year low of Rs. 6001 and a 1-year high of Rs. 7635.

    The market cap of Apollo Hospitals is Rs. 105832.7 Cr. as of 15/7/2025.

    The PE ratios of Apollo Hospitals is 81.69 as of 15/7/2025.

    The PB ratios of Apollo Hospitals is 12.12 as of 15/7/2025

    The Mutual Fund Shareholding in Apollo Hospitals was 15.94% at the end of 15/7/2025.

    You can easily buy Apollo Hospitals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Apollo Hospitals share price is ₹7635 and ₹6001 as of 15/7/2025.

    Please be aware that Apollo Hospitals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    67.17
    +1.73 (+2.64%)
    135.29
    +1.18 (+0.88%)
    684.40
    +9.90 (+1.47%)
    2,598.20
    +16.90 (+0.65%)
    159.64
    +0.64 (+0.40%)
    383.15
    +0.85 (+0.22%)
    159.00
    -1.44 (-0.90%)
    266.45
    -4.15 (-1.53%)
    408.95
    +1.65 (+0.41%)
    403.90
    +1.35 (+0.34%)
    Top Gainers
    4,454.00
    +202.30 (+4.76%)
    8,311.00
    +223.50 (+2.76%)
    1,727.50
    +44.90 (+2.67%)
    684.45
    +14.70 (+2.19%)
    7,360.50
    +140.50 (+1.95%)
    Top Losers
    1,566.40
    -53.40 (-3.30%)
    266.45
    -4.15 (-1.53%)
    1,824.80
    -26.50 (-1.43%)
    756.85
    -7.90 (-1.03%)
    159.00
    -1.44 (-0.90%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -